MYBPC3 and cardiac hypertrophy: Only one further study assessed cMyBP-C in early subclinical CVD disease states; Anand et al. reported cMyBP-C to be associated with myocardial hypertrophy and fibrosis, as potential causes for HF, in aortic stenosis patients (80).